SCHEMBL29633624

SCHEMBL29633624

CCOc1c(C(C)=O)ccc(O)c1C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
TSHR P16473 1/20 0.43
ALDH1A1 P00352 6/20 0.42
HPGD P15428 5/20 0.42
MAPT P10636 4/20 0.42
ALOX15 P16050 3/20 0.42
KDM4E B2RXH2 3/20 0.42
HSD17B10 Q99714 3/20 0.42
RECQL P46063 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
MAPK1 P28482 2/20 0.41
GAA P10253 1/20 0.41
CA12 O43570 2/20 0.40
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA7 P43166 2/20 0.40
CA9 Q16790 2/20 0.40
CA14 Q9ULX7 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL11179896 0.83 ALDH1A1 (0.40) ALDH1A1HPGDMAPTALOX15KDM4E
SCHEMBL28700454 0.80 CYP3A4 (0.41) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL17613830 0.79 HSD17B1 (0.51) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL18152141 0.79 SCN5A (0.46) ALDH1A1HPGDMAPTALOX15KDM4E
SCHEMBL24489018 0.78 TSHR (0.39) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL22946117 0.78 TSHR (0.39) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL29633549 0.78 TSHR (0.39) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL17644154 0.76 HSD17B10 (0.42) TSHRALDH1A1HPGDMAPTALOX15
SCHEMBL10498173 0.75 TSHR (0.55) CYP3A4TSHRALDH1A1HPGDMAPT
SCHEMBL18472947 0.75 CYP3A4 (0.55) CYP3A4TSHRALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12338203-B2 Urea compound for antagonizing LPA1 receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2025-06-24 US disclosed
CN-119823001-A Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2025-04-15 CN disclosed
CN-114206832-B Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2025-04-04 CN disclosed
CN-114206832-A Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2022-03-18 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338203-B2 Urea compound for antagonizing LPA1 receptor LPAR1, LPAR2, LPAR3 CYP3A4 4572/4885TSHR 733/4885ALDH1A1 1250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.